Acadia postpones the start of the phase 2 Pimavanserin for Rigid-compulsive Symptoms in Autism Spectrum Disorder study from March to May 2024:
https://clinicaltrials.gov/study/NCT05999240?cond=Autism&term=pimavanserin&rank=1
https://classic.clinicaltrials.gov/ct2/history/NCT05999240?B=5&A=4&C=merged#StudyPageTop
Acadia postpones the start of the phase 2 Pimavanserin for...
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.02 |
Change
0.000(0.00%) |
Mkt cap ! $2.431B | |||
| Open | High | Low | Value | Volume |
| $19.20 | $19.28 | $18.55 | $6.706M | 355.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 230 | $19.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.04 | 1405 | 19 |
View Market Depth
| Last trade - 14.14pm 05/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$19.03 |
Change
0.000 ( 0.24 %) |
||||
| Open | High | Low | Volume | ||
| $19.12 | $19.26 | $18.55 | 95650 | ||
| Last updated 14.34pm 05/06/2024 ? | |||||
| NEU (ASX) Chart |